Insider · CIK 0001666011
Barrage Khalil
Reports to the SEC for 1 company · NEW YORK, NY
Transactions
15
Companies
1
Filings
8
CIK
0001666011
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2024-03-25 | PTIXProtagenic Therapeutics, Inc.\new · PTIX Common stock OptionsA Award | +$39.2K |
| 2021-05-26 | PTIXProtagenic Therapeutics, Inc.\new · PTIX Common stock NSO OptionsA Award | — |
| 2021-05-03 | PTIXProtagenic Therapeutics, Inc.\newM Exercise/Conversion | +$188K |
| 2021-05-03 | PTIXProtagenic Therapeutics, Inc.\newM Exercise/Conversion | +$78.8K |
| 2021-05-03 | PTIXProtagenic Therapeutics, Inc.\newM Exercise/Conversion | +$210K |
| 2021-05-03 | PTIXProtagenic Therapeutics, Inc.\new · PTIX Common stock OptionsM Exercise/Conversion | — |
| 2021-05-03 | PTIXProtagenic Therapeutics, Inc.\new · PTIX Common stock OptionsM Exercise/Conversion | — |
| 2021-05-03 | PTIXProtagenic Therapeutics, Inc.\new · PTIX Common stock OptionsM Exercise/Conversion | — |
| 2021-05-03 | PTIXProtagenic Therapeutics, Inc.\new · PTIX Common stock OptionsM Exercise/Conversion | — |
| 2021-05-03 | PTIXProtagenic Therapeutics, Inc.\newM Exercise/Conversion | +$56.3K |
| 2020-02-21 | PTIXProtagenic Therapeutics, Inc.\new · PTIX Common stock OptionsA Award | — |
| 2019-11-05 | PTIXProtagenic Therapeutics, Inc.\new · Convertible NoteP Purchase | — |
| 2017-10-16 | PTIXProtagenic Therapeutics, Inc.\new · Non-Qualified Stock Options (Right to Buy)A Award | — |
| 2016-08-08 | PTIXProtagenic Therapeutics, Inc.\newA Award | +$188K |
| 2016-06-17 | PTIXProtagenic Therapeutics, Inc.\newA Award | +$56.3K |
Recent filings
- 4Barrage Khalil0001493152-24-012070SEC(opens sec.gov)
- 4Barrage Khalil0001493152-21-013384SEC(opens sec.gov)
- 4Barrage Khalil0001493152-21-010465SEC(opens sec.gov)
- 4Barrage Khalil0001493152-20-003041SEC(opens sec.gov)
- 5Barrage Khalil0001493152-20-002881SEC(opens sec.gov)
- 4Barrage Khalil0001437749-17-017233SEC(opens sec.gov)
- 4Protagenic Therapeutics, Inc.\new0001437749-16-037066SEC(opens sec.gov)
- 4Protagenic Therapeutics, Inc.\new0001437749-16-034199SEC(opens sec.gov)
Companies
Address
149 FIFTH AVENUE, SUITE 500
NEW YORK, NY, 10010